You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

New Developments in Obviousness-Type Double Patenting;Should Sun v. Lilly Be Reheard en Banc ?;Glaxo Says Genentech Is Infringing Antibody-Purification Patents;Two Generic Drug Makers Sue Each Other;Docetaxel Patents Invalid for Obviousness;CAFC Allows Suit of Teva Against Eisai to Go Forward;Japanese Patent Application Found Deficient;Rights to Human Fibroblast Interferon at Stake